医药中间体是指在药物合成过程中作为关键步骤的反应产物或原料物质,它们通常是化学结构较为简单的化合物,通过一系列化学反应可以转化为最终的药物成品。这些中间体在制药工业中扮演着重要角色,是实现复杂药物分子合成的关键组成部分。
特点医药中间体的研发和生产是一个复杂的过程,通常包括以下几个步骤:
随着化学合成技术的进步和新技术的应用(如绿色化学、计算机辅助设计等),医药中间体的研发与生产正朝着更加高效、环保的方向发展。同时,对药物分子结构的深入理解也为开发更有效的治疗方案提供了更多可能性。
中文名称 | 英文名称 | CAS号 | 化学式 | 结构式图片 |
---|---|---|---|---|
—— | 5-chloro-2-cyclopropyl-1,6-dihydro-6-oxo-4-pyrimidinecarboxylic acid | 858956-26-0 | C8H7ClN2O3 |
|
—— | 6-(thiophen-2-yl)-4-(trifluoromethyl)pyridin-2(1H)-one | 22123-11-1 | C10H6F3NOS |
|
—— | Cytidine, 2'-deoxy-5-fluoro- | 10356-76-0 | C9H12FN3O4 |
|
—— | 2-fluoro-4-methoxy-1-(trifluoromethyl)benzene | 1214344-33-8 | C8H6F4O |
|
—— | 3-iodo-1-(phenylsulfonyl)-1H-indole-7-carbonitrile | 96631-87-7 | C15H9IN2O2S |
|
—— | (-)-Tabernemontanine | 2134-98-7 | C21H26N2O3 |
|
—— | 2-Fluoro-9-(2,3,5-tri-o-acetylpentofuranosyl)-9h-purin-6-amine | 15811-32-2 | C16H18FN5O7 |
|
—— | 1,2:3,4-Di-O-isopropylidene-6-deoxy-6-tosyl-alpha-D-galactopyranose | 4478-43-7 | C19H26O8S |
|
—— | 6-amino-2-mercapto-3H-pyrimidin-4-one monohydrate | 65802-56-4 | C4H7N3O2S |
|
—— | 3,5-Bis-o-(4-chlorobenzoyl)-2-deoxypentofuranosyl chloride | 21740-23-8 | C19H15Cl3O5 |
|
—— | 1-(4-carboxyphenyl)-3-methyl-5-pyrazolone | 60875-16-3 | C11H10N2O3 |
|
—— | 4-Amino-8-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-oxopyrido[2,3-d]pyrimidine-6-carboxamide | 36707-00-3 | C13H15N5O6 |
|
—— | (-)-methyl (1S,2S,3R,4R)-3-[(1S)-1-(acetylamino)-2-ethylbutyl]-4-amino-2-hydroxycyclopentanecarboxylate | 229615-05-8 | C15H28N2O4 |
|
—— | 2,3,4,6-tetra-O-benzyl-1-C-(dichloromethyl)-D-glucopyranose | 140658-50-0 | C35H36Cl2O6 |
|
—— | ethyl 4-oxo-1H-1,10-phenanthroline-3-carboxylate | 49590-04-7 | C15H12N2O3 |
|
—— | 5-anilino-2-hydroxy-penta-2,4-dienal-phenylimine; hydrochloride | 17315-76-3 | C17H16N2O*ClH |
|
—— | 4-Amino-1-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-methoxypyrimidin-2-one | 37805-90-6 | C10H15N3O6 |
|
—— | 2'-Chlor-2'-desoxy-Ψ-uridin | 4753-04-2 | C9H11ClN2O5 |
|
—— | (S)-methyl-N-(1-phenylethyl)-2-azabicyclo[2.2.1]hept-5-ene-3-carboxylate | 130194-96-6 | C16H19NO2 |
|
—— | Ethyl 3-(quinolin-4-YL)prop-2-enoate | 69976-10-9 | C14H13NO2 |
|
—— | (2R,3S,4R,5R,6S)-5-amino-6-[(2R,4R,5R)-5-amino-6-[(2R,3S,4R,5R,6R)-5-amino-4,6-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-4-hydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-2-(hydroxymethyl)oxane-3,4-diol | 78341-33-0 | C18H35N3O13 |
|
—— | 4-[(R)-[(2S,5R)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl]-hydroxymethyl]quinolin-6-ol | 524-63-0 | C19H22N2O2 |
|
—— | (+)-1-phenyl-1-[2]pyridyl-ethanol | 19490-92-7 | C13H13NO |
|
—— | 2-(3-isopropylphenyl)pyridine | 1314921-39-5 | C14H15N |
|
—— | (3R,6R)-6-[(1R,3aS,7aR)-4-[2-[(5S)-5-hydroxy-2-methylenecyclohexylidene]ethylidene]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-1-yl]-2-methylheptane-2,3-diol | 55721-11-4 | C27H44O3 |
|
—— | 2',3'-dideoxy-N6-benzoyl-adenosine | 77244-86-1 | C17H17N5O3 |
|
—— | ethyl 5-oxo-2H-1,2-oxazole-3-carboxylate | 88393-81-1 | C6H7NO4 |
|
—— | 3-Amino-6-(chloromethyl)-2-pyrazinecarbonitrile 4-oxide | 40127-89-7 | C6H5ClN4O |
|
—— | Clicoemodin | 34298-85-6 | C21H20O10 |
|
—— | 4-[(S)-[(2R,4R,5S)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl]-hydroxymethyl]quinolin-6-ol | 524-63-0 | C19H22N2O2 |
|
—— | 6-(α-Styryl)pyridazin-3(2H)-one | 83516-65-8 | C12H10N2O |
|
—— | cis-1-Methyl-2-<2-(2-thienyl)vinyl)>-Δ<sup>2</sup>-tetrahydropyrimidin-tartrat | 21573-92-2 | C4H6O6*C11H14N2S |
|
—— | (5R)-1-benzyl-5-ethoxyimidazolidine-2,4-dione | 65855-02-9 | C12H14N2O3 |
|
—— | 6-bromobenzothiazole-2-carbaldehyde | 53218-26-1 | C8H4BrNOS |
|
—— | 4-(4-bromo-1H-pyrazol-1-yl)benzoic acid | 926212-84-2 | C10H7BrN2O2 |
|
—— | (Z)-N,N-Dimethyl-4-(2-(quinolin-4-yl)vinyl)aniline | 897-55-2 | C19H18N2 |
|
—— | dimethyl diazomethylphosphonate | 27491-70-9 | C3H8N2O3P |
|
—— | 6,7-dichloro-1H-indole-2-carboxylic acid | 383132-13-6 | C9H5Cl2NO2 |
|
—— | 1-Methyl-6-oxo-pyridazine-3-carboxylate | 100047-66-3 | C6H5N2O3- |
|
—— | 3-Azatricyclo<3.2.1.0<sup>2,4exo</sup>>-octan | 279-82-3 | C7H13N |
|
—— | Phytonadione epoxide, (E,2S,3R)- | 25486-55-9 | C31H46O3 |
|
—— | 2,3,4,6-tetra-O-benzyl-L-idopyranose | 4132-28-9 | C34H36O6 |
|
—— | Tetra-O-benzyl-D-galactopyranose | 4132-28-9 | C34H36O6 |
|
—— | (5R)-5-aminopiperidin-2-one | 1002566-99-5 | C5H10N2O |
|
—— | 1,2-dihydro-2-oxo-6-(2-pyridyl)-3-pyridinecarbonitrile | 56304-74-6 | C11H7N3O |
|
—— | 6-bromo-quinoxalin-2-ylamine | 1071605-38-3 | C8H6BrN3 |
|
—— | 2-Cyano-3-pyridin-3-ylprop-2-enoic acid | 103029-74-9 | C9H6N2O2 |
|
—— | (E)-2-(5-amino-1,2,4-thiadiazol-3-yl)-2-(ethoxyimino)acetic acid | 75028-24-9 | C6H8N4O3S |
|
—— | 7-Methylamino-4-trifluoromethyl-chromen-2-one | 53518-14-2 | C11H8F3NO2 |
|
—— | Methyl 4-hydroxy-2-(trifluoromethyl)thieno[3,4-b]pyridine-7-carboxylate | 175203-39-1 | C10H6F3NO3S |
|